Investor Presentaiton

Q4FY22 Performance Snapshot 3. & گاه Q4FY22 Key Highlights METROPOLIS The Pathology Specialist Revenue Rs. 306 Crores +5% YoY Non-Covid Revenue Rs. 268 Crores +7% YoY EBITDA (Before CSR & ESOP) Rs. 83 Crores -20% YoY No. of Patients 3.4 Mn +7% YOY EBITDA Margin (Before CSR & ESOP) 27.0% No. of Tests 6.6 Mn +1% YoY Including Hitech Diagnostics from 22nd Oct, 2021 Blood Tests | Diagnostics | Wellness 5

View entire presentation